Terminated PHASE1 INTERVENTIONAL 2-arm NCT00743470

A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects

A Comparison of the Bioavailability of Rifabutin With and Without Lopinavir/Ritonavir in Healthy Adult Subjects

Sponsor: Abbott

Interventions lopinavir/ritonavir rifabutin

Updated 6 times since 2017 Last updated: Oct 29, 2010 Started: Aug 31, 2008 Primary completion: Oct 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Abbott

See all terminations from Abbott

Other HIV trials with similar outcome

Browse all HIV trials

A PHASE1 clinical study on HIV and Tuberculosis, this trial is terminated or withdrawn. The trial is conducted by Abbott and has accumulated 6 data snapshots since 2008. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE1
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE1
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE1
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Terminated PHASE1

First recorded

Aug 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Abbott

Data source: Abbott

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Waukegan, United States